NDC 16590-276 Reprexain

View Dosage, Usage, Ingredients, Routes, UNII

Product Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.
NDC Product Code:
16590-276
Proprietary Name:
Reprexain
Product Type: [3]
INACTIVATED PRODUCT and EXCLUDED the from NDC Directory
Labeler Name: [5]
Labeler Code:
16590
Start Marketing Date: [9]
12-16-2008
Listing Expiration Date: [11]
12-31-2017
Exclude Flag: [12]
I
Code Navigator:

Product Characteristics

Color(s):
WHITE (C48325)
YELLOW (C48330)
Shape:
OVAL (C48345)
ROUND (C48348)
Size(s):
14 MM
10 MM
Imprint(s):
IP;146
IP;117
Score:
1

Code Structure Chart

Product Details

What is NDC 16590-276?

The NDC code 16590-276 is assigned by the FDA to the product Reprexain which is product labeled by Stat Rx Usa. The product's dosage form is . The product is distributed in 5 packages with assigned NDC codes 16590-276-30 60 tablet in 1 bottle, plastic , 16590-276-40 40 tablet in 1 bottle, plastic , 16590-276-60 60 tablet in 1 bottle, plastic , 16590-276-71 100 tablet in 1 bottle, plastic , 16590-276-90 90 tablet in 1 bottle, plastic . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

What are the uses for Reprexain?

INDICATIONS AND USAGECarefully consider the potential benefits and risks of REPREXAIN™ and other treatment options before deciding to use REPREXAIN™. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS). REPREXAIN™ tablets are indicated for the short-term (generally less than 10 days) management of acute pain. REPREXAIN™ is not indicated for the treatment of such conditions as osteoarthritis or rheumatoid arthritis.

Which are Reprexain UNII Codes?

The UNII codes for the active ingredients in this product are:

What is the NDC to RxNorm Crosswalk for Reprexain?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
  • RxCUI: 858778 - HYDROcodone bitartrate 5 MG / ibuprofen 200 MG Oral Tablet
  • RxCUI: 858778 - hydrocodone bitartrate 5 MG / ibuprofen 200 MG Oral Tablet
  • RxCUI: 858784 - REPREXAIN 5 MG / 200 MG Oral Tablet
  • RxCUI: 858784 - hydrocodone bitartrate 5 MG / ibuprofen 200 MG Oral Tablet [Reprexain]
  • RxCUI: 858784 - Reprexain 5/200 (hydrocodone / ibuprofen) Oral Tablet

* Please review the disclaimer below.

Product Footnotes

[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".